Epstein Secrets

Bloomberg <https://www.bloomberg.corn/news/articles/2021-05-05/moderna-booster-shot-bolsters-antibodies- against-variant-strains?srnd—premium> (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive

." The New York Times <https://www.nytimes.com/2021/05/05/science/moderna-booster-variants-covid.html> (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against the

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid- stage vaccine trial, and it found that its COVID booster shots "gave positive

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th

f it's approved." Bloomberg <https://www.bloomberg.com/news/articles/2020-11-30/modema-plans-to-seek-u-s-eu-clearance-for- covid-19-vaccine> (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Modena shot in August," while the EU, Canada, and

In an interview with the New York Times <https://vvwvv.nytimes.com/2020/11/30/health/covid-vaccine- modema.html> (11/30, Grady, 18.61M), Moderna CEO Stephane Bancel announced the first vaccinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Stree

ry contact with the health system to come with the offer of a vaccine." Moderna Study Finds Vaccine Is Effective Against Variants. Bloomberg (5/5, Langreth, 3.57M) reports that Moderna published the latest results from its mid-stage vaccine trial, and it found that its COVID booster shots "gave positive

wo weeks after the booster shots, and the trial is continuing to gather more data." The New York Times (5/5, Mandavilli, 20.6M) reports Moderna CEO Stephane Bancel said of the results, "We are encouraged by these new data, which reinforce our confidence that our booster strategy should be protective against th